相关实验视频

Updated: Sep 17, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

基于TCR的肝细胞癌细胞免疫疗法:进展,挑战和前景

Wanting Zeng^1,2, Wei Zhu¹, Guosheng Yuan¹

¹State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education; Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangdong Provincial Clinical Research Center for Viral Hepatitis, Guangdong Institute of Hepatology, Guangdong Provincial Research Center for Liver Fibrosis Engineering and Technology, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.

Cancer immunology, immunotherapy : CII

|July 1, 2025

概括

肝细胞癌 (HCC) 的治疗方法不足. T细胞受体 (TCR) -T疗法对HCC有希望,目前正在进行的研究重点是抗原标和未来的发展.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

肝细胞癌 (HCC) 是一种全球普遍存在的恶性瘤,目前的治疗治疗结果有限.
采用细胞疗法 (ACT),特别是T细胞受体 (TCR) -T疗法,正在成为癌症治疗的重要研究领域.

研究的目的:

审查HCC的流行病学,并评估当前一线治疗的疗效.
引入TCR-T疗法作为HCC的潜在治疗方法.
根据HCC治疗的抗原标对现有的TCR-T研究进行分类.

主要方法:

关于TCR-T治疗HCC的已发表研究的综合文献综述.
对已注册临床试验的分析,这些试验调查了HCC中TCR-T疗法.
根据TCR-T治疗中使用的特定抗原点对研究进行分类.

主要成果:

鉴定和分类各种抗原点正在探索TCR-T疗法在HCC.
概述了该领域目前出版的文献和临床试验的现状.
讨论与当前的TCR-T研究和HCC应用相关的局限性和挑战.

结论:

TCR-T疗法显示出作为HCC未来治疗方式的重大前景.
进一步的研究和开发是必要的,以克服现有的挑战,并优化TCR-T治疗HCC.
抗原向是TCR-T治疗肝细胞癌的发展的一个关键方面.

关键词:

收养细胞疗法采用细胞疗法.细胞免疫疗法细胞免疫疗法乙型肝炎病毒 (HBV)肝细胞癌是肝细胞癌.这就是T细胞.这种T细胞受体是T细胞受体.

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.